173 related articles for article (PubMed ID: 38512625)
1. Nomogram for preoperative differentiation of benign and malignant breast tumors using contrast-enhanced cone-beam breast CT (CE CB-BCT) quantitative imaging and assessment features.
Su T; Zheng Y; Yang H; Ouyang Z; Fan J; Lin L; Lv F
Radiol Med; 2024 May; 129(5):737-750. PubMed ID: 38512625
[TBL] [Abstract][Full Text] [Related]
2. Radiomics nomogram for predicting axillary lymph node metastasis-a potential method to address the limitation of axilla coverage in cone-beam breast CT: a bi-center retrospective study.
Zhu Y; Ma Y; Zhang Y; Liu A; Wang Y; Zhao M; Li H; He N; Wu Y; Ye Z
Radiol Med; 2023 Dec; 128(12):1472-1482. PubMed ID: 37857980
[TBL] [Abstract][Full Text] [Related]
3. Preoperative contrast-enhanced CT-based radiomics nomogram for differentiating benign and malignant primary retroperitoneal tumors.
Xu J; Guo J; Yang HQ; Ji QL; Song RJ; Hou F; Liang HY; Liu SL; Tian LT; Wang HX
Eur Radiol; 2023 Oct; 33(10):6781-6793. PubMed ID: 37148350
[TBL] [Abstract][Full Text] [Related]
4. Optimal acquisition time to discriminate between breast cancer subtypes with contrast-enhanced cone-beam CT.
Chen JT; Zhou CY; He N; Wu YP
Diagn Interv Imaging; 2020 Jun; 101(6):391-399. PubMed ID: 32008993
[TBL] [Abstract][Full Text] [Related]
5. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy.
Uhlig J; Fischer U; Surov A; Lotz J; Wienbeck S
Eur J Radiol; 2018 Feb; 99():9-16. PubMed ID: 29362157
[TBL] [Abstract][Full Text] [Related]
7. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of a CT-based radiomics nomogram for discrimination of benign and early stage malignant ovarian tumors.
Chen J; Yang F; Liu C; Pan X; He Z; Fu D; Jin G; Su D
Eur J Med Res; 2023 Dec; 28(1):609. PubMed ID: 38115095
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
Wienbeck S; Fischer U; Luftner-Nagel S; Lotz J; Uhlig J
Eur Radiol; 2018 Sep; 28(9):3731-3741. PubMed ID: 29594402
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of CT-based radiomics nomogram for the classification of benign parotid gland tumors.
Zheng M; Chen Q; Ge Y; Yang L; Tian Y; Liu C; Wang P; Deng K
Med Phys; 2023 Feb; 50(2):947-957. PubMed ID: 36273307
[TBL] [Abstract][Full Text] [Related]
11. Intra- and peritumoral radiomics for predicting malignant BiRADS category 4 breast lesions on contrast-enhanced spectral mammography: a multicenter study.
Zhang S; Shao H; Li W; Zhang H; Lin F; Zhang Q; Zhang H; Wang Z; Gao J; Zhang R; Gu Y; Wang Y; Mao N; Xie H
Eur Radiol; 2023 Aug; 33(8):5411-5422. PubMed ID: 37014410
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Radiomics Models Based on Computed Tomography for Distinguishing Between Benign and Malignant Thyroid Nodules.
Kong D; Zhang J; Shan W; Duan S; Guo L
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):978-985. PubMed ID: 35759774
[TBL] [Abstract][Full Text] [Related]
13. CT values of contrast-enhanced CBBCT: A useful diagnostic tool for benign and malignant breast lesions.
Wei W; Yi XL; Yang J; Liao H; Su D
Acta Radiol; 2023 Aug; 64(8):2379-2386. PubMed ID: 37287251
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors.
Ren C; Wang S; Zhang S
Cancer Imaging; 2020 Jan; 20(1):5. PubMed ID: 31931874
[TBL] [Abstract][Full Text] [Related]
15. Nomogram based on spectral CT quantitative parameters and typical radiological features for distinguishing benign from malignant thyroid micro-nodules.
Song Z; Li Q; Zhang D; Li X; Yu J; Liu Q; Li Z; Huang J; Zhang X; Tang Z
Cancer Imaging; 2023 Jan; 23(1):13. PubMed ID: 36703218
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
[TBL] [Abstract][Full Text] [Related]
17. A CT-based radiomics nomogram for differentiation of lympho-associated benign and malignant lesions of the parotid gland.
Zheng YM; Xu WJ; Hao DP; Liu XJ; Gao CP; Tang GZ; Li J; Wang HX; Dong C
Eur Radiol; 2021 May; 31(5):2886-2895. PubMed ID: 33123791
[TBL] [Abstract][Full Text] [Related]
18. A CT-based radiomics nomogram for distinguishing between benign and malignant bone tumours.
Sun W; Liu S; Guo J; Liu S; Hao D; Hou F; Wang H; Xu W
Cancer Imaging; 2021 Feb; 21(1):20. PubMed ID: 33549151
[TBL] [Abstract][Full Text] [Related]
19. A CT-based radiomics nomogram for differentiation of benign and malignant small renal masses (≤4 cm).
Feng S; Gong M; Zhou D; Yuan R; Kong J; Jiang F; Zhang L; Chen W; Li Y
Transl Oncol; 2023 Mar; 29():101627. PubMed ID: 36731307
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis.
Uhlig J; Uhlig A; Biggemann L; Fischer U; Lotz J; Wienbeck S
Eur Radiol; 2019 Mar; 29(3):1194-1202. PubMed ID: 30255249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
